The ketogenic diet (KD) is increasingly being recognized as more than a simple metabolic intervention in cancer therapy. Emerging evidence suggests that KD may function as a systems-level immunometabolic sensitization strategy capable of enhancing therapeutic responsiveness through interconnected biologic mechanisms. M...
M. S. Mannan, M. W. Khan, Muhammad Haseeb Khan et al.· Medical Oncology· 0 citations
Therapy-related myeloid neoplasms (t-MNs), including therapy-related acute myeloid leukemia and myelodysplastic syndrome, are recognized late complications of cytotoxic therapies. With the expanding use of autologous stem cell transplantation (ASCT) and chimeric antigen receptor T-cell (CAR-T) therapy, the risk, timi...
Adeena Musheer, M. S. Mannan, M. W. Khan et al.· Annals of Hematology· 0 citations
Combined therapy shows encouraging results in selected MET, post-TKI NSCLC, however, reliance on single-arm data warrants further randomized controlled trials.
Eshal Amir, M. W. Khan, M. Mannan et al.· American Journal of Clinical...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.